The Science and Politics of Genetically Modified Humans
By Richard Hayes,
Worldwatch
| 07. 01. 2002
July/August 2002
The new human genetic technologies are arguably the most consequential technologies ever developed. Many applications have great potential to prevent disease and alleviate suffering, but others would open the door to a new, high-tech eugenics that could destabilize human biology and undermine the foundations of civil society.
Humanity needs a crash course in the science and politics of the new human genetic technologies. We need to distinguish benign applications from pernicious ones, and we need to adopt policies affirming the former and proscribing the latter. We need to repudiate eugenic political ideologies and deepen our commitment to the integrity of the human species and the dignity of all people. We need to do this on a global scale and within less than a decade.
Two new technologies are of critical concern: reproductive cloning and inheritable genetic modification. Reproductive cloning is the creation of a genetic near-duplicate of an existing person. If I cloned myself, would the child be my son or my twin brother? In truth, he would be neither. He would be a new category of biological...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...
By Staff, The Medicine Maker | 03.21.2025
"The Promise and Peril of CRISPR" cover by Johns Hopkins University Press
As a paediatrician taking care of children with sickle cell disease, Neal Baer, a Harvard Medical School graduate, was in awe of the power of CRISPR technologies. Later...
